首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer science

缩写:CANCER SCI

ISSN:1347-9032

e-ISSN:1349-7006

IF/分区:4.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引6291条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jingxuan Yu,Gang Yu,Yuan Liu et al. Jingxuan Yu et al.
Clear cell renal cell carcinoma (ccRCC) is a highly aggressive malignancy with limited treatment options. Although RASD2, which encodes a Ras-related GTP-binding protein, has been linked to melanoma progression, its role in ccRCC remains un...
Takaaki Tanaka,Masato Fujitani,Masataka Taoka et al. Takaaki Tanaka et al.
Osimertinib is the standard first-line treatment for advanced EGFR-mutant non-small cell lung cancer. However, acquired resistance invariably develops, and identifying novel resistance pathways is clinically important as a substantial porti...
Nana Kamakura,Minji Jo,Motoko Takahashi et al. Nana Kamakura et al.
Cell division is a fundamental cellular process that ensures propagation of genetic material to daughter cells. This process relies on the fidelity of DNA replication and chromosome segregation and is primarily regulated by sequential activ...
Huaitao Wang,Takashi Semba,Atsuko Yonemura et al. Huaitao Wang et al.
Cancer-associated fibroblasts (CAFs) are major stromal components of the tumor microenvironment (TME) and play diverse roles in gastrointestinal (GI) cancer progression, immunity, and therapeutic resistance. However, the heterogeneity, tiss...
Yutaro Nagano,Hiroshi Yokouchi,Ryota Saito et al. Yutaro Nagano et al.
Non-small cell lung cancers (NSCLC) harboring uncommon epidermal growth factor receptor (EGFR) mutations (UMs) are clinically heterogeneous, and the optimal first-line EGFR tyrosine kinase inhibitor (EGFR-TKI), as well as the role of subseq...
Keitaro Matsuo,Hidemi Ito Keitaro Matsuo
Early-onset colorectal cancer (EOCRC) is increasingly described as a rising disease entity, but the descriptive epidemiologic conditions required to interpret that rise remain incompletely articulated. Using Japanese public summary statisti...
Ichiro Onoyama,W Rod Hardy,Shoichiro Takeishi et al. Ichiro Onoyama et al.
Aberrant epigenetic modification is one of the characteristics of the cancer genome. DNA hypermethylation of cytosine-phospho-guanine (CpG) islands, a hallmark of cancer cells, is well-studied and contributes to cancer development by silenc...
Kaibo Guo,Yuqian Feng,Jiamin Lu et al. Kaibo Guo et al.
Pyroptosis, a form of programmed cell death mediated by gasdermin proteins, has gained attention for its dual role in colorectal cancer (CRC) progression and therapy. While chronic pyroptosis-driven inflammation can promote tumorigenesis, a...
Toru Odate,Tetsuo Kondo Toru Odate
Anaplastic thyroid carcinoma (ATC) is a rare malignancy characterized by an extremely aggressive clinical course, in contrast to the typically indolent behavior of most thyroid carcinomas. Recent advances in high-throughput sequencing techn...
Nobuaki Matsubara,Ken Saijo,Yasushi Shimizu et al. Nobuaki Matsubara et al.
The dose escalation part of the first-in-human study of E7130 in patients with advanced solid tumors determined the Recommended Phase 2 Dose (RP2D) of E7130 (480 μg/m2 Q3W). The dose expansion part (presented here) examined safety/prelimin...